Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

SGX's profit rose 44% in 2nd quarter

Article Abstract:

Fiscal second-quarter net profit for Singapore Exchange Ltd. rose by 44% to reach $109.4 mil, buoyed by new listing increases and high trading volumes. Revenue increased 63%, while securities market revenue rose 90%. SGX had 44 new listings, up from 28 from the prior year.

Author: Venkat, P.R., Se Young Lee
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2008
Singapore, Singapore Exchange Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


ICAP posts 38% profit gain on higher volume, revenue

Article Abstract:

Fiscal first-half net profit for UK interdealer broker ICAP PLC rose 38% to $214 mil, driven by an increase in revenue in electronic-broking. Profit before impairment, amortization, and tax increased 34%, but was negatively impacted by a weaker dollar.

Author: MacDonald, Alistair, Patrick, Margot
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
United Kingdom, ICAP PLC

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Securities industry, Company sales and earnings, Company earnings/profit, Financial report
Similar abstracts:
  • Abstracts: ICAP revenue, profit decline: dollar is cited. Van der Moolen posts a loss after Goodwill charge. Euronext reports revenue increase on brisk market
  • Abstracts: AWD cites training costs as earnings decline 8.3%. ING expects scant problems from credit markets as net soars
  • Abstracts: Electronics giant seeks a cure in health care: fleeing chips and TVs, Philips makes big bet on aging consumers
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.